Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

SARS-CoV-2; transmission; masks; medical masks; FFP masks; N95 masks; cloth masks; respiratory side effects; cough; dyspnea; sputum; COVID-19; β-Thalassemia; mortality; critical care; pandemic; biomarkers; chronic obstructive pulmonary disease; exacerbations; lung aging; oxidative stress; sleep deprivation; exercise; cardiovascular; cognitive; vitamin D; hospitalization; ICU admission; intubation; mechanical ventilation; acute respiratory distress syndrome; open lung biopsy; histology; diffuse alveolar damage; pulmonary fibrosis; idiopathic pulmonary fibrosis; outcomes; COPD; respiratory muscle training; cognitive impairment; inspiratory muscle training; expiratory muscle training; FEV1; diaphragmatic thickness fraction; mandibular advancement devices (MADs); obstructive sleep apnea (OSA); dental effects; skeletal effects; adults; influenza; human; troponin; cardiovascular infections; virus diseases; usTnT; tuberculosis; antituberculotic drugs; host immune response; pulmonary rehabilitation; breakthrough COVID-19 hospitalizations; clinical outcomes; SARS-CoV-2 IgG Spike responses; vaccine-induced immunity; recovery; septic shock; venous return; mean circulatory filling pressure; stressed volume; unstressed volume; rest volume; cardiovascular dynamics; hemodynamics; anesthesiology; intensive care medicine; latent tuberculosis; inflammatory rheumatoid disease; interferon-inducible protein-10; one-lung ventilation; supine position; iloprost; oxygenation; lung mechanics; pulmonary embolism; venous thromboembolism; bleeding complications; anticoagulant treatment; prediction of bleeding; in-hospital bleeding; vaccination; risk factors; effectiveness; fractional exhaled NO; sevoflurane; propofol; eosinophil blood count; thyroidectomy; asthma; sarcopenia; low muscle mass; inflammation; respiratory disease; diagnosis; D-dimers; ischemia modified albumin; microparticles; microRNAs; Factor VIII; C-reactive protein (CRP); community-acquired pneumonia (CAP); prognosis; length of stay; antibody; infection; immunization; digitalization of healthcare; control; severity; urokinase plasminogen activator receptor; PM2.5; air pollution; respiratory diseases; pneumonia; upper respiratory infections; emergency department; n/a